Login

Christoph Vilanek, CEO of Freenet AG, speaking at the 10th International Brand Colloquium in 2013. 00:10:00

Share On Facebook Share On Twitter

Christoph Vilanek is Chairman-Mgmt Board/CEO at freenet AG.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:00:00
Michael Hunt CFO of ReNeuron Group (RENE) at SHARES Innovators and Investors Forum - Michael Hunt, Chief Financial Officer, ReNeuron Group
00:10:00
Patrick Stokes (Gibson Dunn) Discusses the Importance of the Foreign Extortion Prevention Act for Companies | Barbara L. Becker - Chair & Managing Partner of gibson dunn
00:10:00
Pioneering Growth: Crusader Resources at One-to-One Mining Conference
00:10:00
HSBC Initiates Buy Ratings on Marriott and Booking Holdings Amid Consumer Spending Concerns
00:10:00
Empowering SMEs: Insights from Teoh Kok Lin, Andrew Wong, and Nazrin Hassan
00:10:00
Powering Collaboration Through Love | Mary Powell, CEO ,Sunrun Inc.
00:10:00
Focus exclusively on founders starting companies that are pre-traction|Anamitra Banerji,Managing Director, Afore Capital
00:10:00
Eurazeo's Strategic Shift: Adapting Amid Sector Dislocations and Embracing Sustainability Goals | Virginie Morgon, CEO, Eurazeo.
00:10:00
Invest in only a few new companies each year, allowing them to concentrate their time|Xia Zhi Jin,Managing Partner,Vertex Ventures
00:10:00
Interview with Bronwyn Barnes, Executive Chairman of Indiana Resources
00:10:00
UTI AMC's 2009 Milestones: Exam Opening, Subscriber Growth, and Key Industry Insights | Imtaiyazur Rahman , CEO , UTI Asset Management.
00:10:00
leads the AI-first startup incubator at the Allen Institute for Artificial Intelligence|Jacob Colker,Managing Director,Allen Institute for AI (AI2) Incubator

© 2017 - Neuhu+